The United Laboratories International Holdings Limited (HKG: 3933)
Hong Kong
· Delayed Price · Currency is HKD
11.62
+0.50 (4.50%)
Jan 21, 2025, 4:08 PM HKT
The United Laboratories International Holdings Revenue
The United Laboratories International Holdings had revenue of 7.18B CNY in the half year ending June 30, 2024, with 38.48% growth. This brings the company's revenue in the last twelve months to 14.01B, up 7.28% year-over-year. In the year 2023, The United Laboratories International Holdings had annual revenue of 13.74B with 21.22% growth.
Revenue (ttm)
14.01B CNY
Revenue Growth
+7.28%
P/S Ratio
1.40
Revenue / Employee
933.94K CNY
Employees
15,000
Market Cap
21.11B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.74B | 2.41B | 21.22% |
Dec 31, 2022 | 11.33B | 1.63B | 16.81% |
Dec 31, 2021 | 9.70B | 930.95M | 10.61% |
Dec 31, 2020 | 8.77B | 379.89M | 4.53% |
Dec 31, 2019 | 8.39B | 882.01M | 11.74% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Alibaba Health Information Technology | 31.39B |
Sino Biopharmaceutical | 29.86B |
Akeso | 2.01B |